ALIMENA, Giuliana

ALIMENA, Giuliana  

DIPARTIMENTO DI BIOTECNOLOGIE CELLULARI ED EMATOLOGIA (attivo dal 01/01/1900 al 01/11/2018)  

Mostra prodotti
Risultati 1 - 20 di 365 (tempo di esecuzione: 0.034 secondi).
Titolo Data di pubblicazione Autore(i) File
5 '-Azacitidine in myelodysplastic syndromes with inversion of chromosome 3 2011 M., Breccia; L., Cannella; M., Santopietro; G., Loglisci; V., Federico; A., Salaroli; M., Nanni; M., Mancini; Alimena, Giuliana
5'-Azacitidine for therapy-related myelodysplastic syndromes after non-Hodgkin lymphoma treatment. 2011 Breccia, M; Salaroli, A; Loglisci, G; Martelli, Maurizio; D'Elia, Gm; Nanni, M; Mauro, Francesca Romana; Alimena, Giuliana
5-Azacitidine efficacy and safety in patients aged >65 years with myelodysplastic syndromes outside clinical trials. 2012 Breccia, M; Loglisci, G; Salaroli, A; Serrao, A; Petrucci, L; Mancini, M; Alimena, Giuliana
5q- chromosome in a case of acute non-lymphocytic leukemia: the marker of a polyphasic disease? 1982 Alimena, Giuliana; Gastaldi, R; De Cuia, Mr; Lombardi, A; Dallapiccola, B.
A case of Burkitt lymphoma-L3 ALL with t(8;14)translocation, developed 10 years after Hodgkin's disease. 1985 Mandelli, Franco; Martelli, Maurizio; Cimino, Giuseppe; Alimena, Giuliana; Anselmo, Anna Paola; De Cuia, Mr; Gastaldi, R; Arcese, W; Papa, G.
A collaborative study of the relationship of the morphological type of acute non-lymphocytic leukemia with patients'age and karyotype. 1982 Rowley, Yd; Alimena, Giuliana; Garson, Om; Hagemeijer, A; Mitelman, F; Prigogina, E. L.
A comparison of imatinib 400 mg and 800 mg daily in the front-line treatment of high-risk, Philadelphia-positive chronic myeloid leukemia: a European LeukemiaNet Study 2009 Baccarani, M; Rosti, G; Castagnetti, F; Haznedaroglu, I; Porkka, K; Abruzzese, E; Alimena, Giuliana; Ehrencrona, H; HJORTH HANSEN, H; Kairisto, V; Levato, L; Martinelli, Giovanni; Nagler, A; LANNG NIELSEN, J; Ozbek, U; Palandri, F; Palmieri, F; Pane, F; REGE CAMBRIN, G; Russo, D; Specchia, G; Testoni, N; WEISS BJERRUM, O; Saglio, G; Simonsson, B.
A cytogenetic analysis in patiens with secondary hematological disorders. 1987 Zaccaria, A; Alimena, Giuliana; Billstrom, R; Carbonell, F; Castoldi, Gl; Fuscaldo, K; Gastaldi, R; Hecth, F; Mitelman, F; Hossfeld, Dk; Rosti, G; Sandberg, Aa; Testoni, N; Tura, S.
A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa. Writing Committe for the Collaborative CML prognostic factor project groups 1998 Hasford, J; Pfirrmann, M; Hehlmann, R; Alimena, Giuliana
a prospective study of a-interferon and autologus bone marrow transplantation in chronic myeloid leukemia 1999 Meloni, G.; Russo, D.; Baccarani, M.; Testoni, N.; Martinelli, G.; Fanin, R.; Zuffa, E.; Giannantonio, R.; Alimena, Giuliana; Saglio, G.; Mandelli, Franco; Tura, S.
A randomized phase 3 study of tipifarnib compared with best supportive care, including hydroxyurea, in the treatment of newly diagnosed acute myeloid leukemia in patients 70 years or older 2009 J. L., Harousseau; Martinelli, Giovanni; W. W., Jedrzejczak; J. M., Brandwein; D., Bordessoule; T., Masszi; G. J., Ossenkoppele; J. A., Alexeeva; G., Beutel; J., Maertens; M. B., Vidriales; H., Dombret; Thomas X., Burnett Ak; T., Robak; N. K., Khuageva; A. K., Golenkov; E., Tothova; L., Mollgard; Y. C., Park; A., Bessems; P., De Porre; A. J., Howes; Alimena, Giuliana
A simple prognostic scoring system for newly diagnosed cytogenetically normal acute myeloid leukemia: retrospective analysis of 530 patients 2011 Malagola, M; Skert, C; Vignetti, Marco; Piciocchi, A; Martinelli, Giovanni; Alimena, Giuliana; Mecucci, C; Testoni, N; Iacobucci, I; Clavio, M; Gobbi, M; Candoni, A; Damiani, D; Bocchia, M; Lauria, F; Zaccaria, A; Mazza, P; Visani, G; Peli, A; Colombi, C; Cancelli, V; Mancini, M; Foa, Roberto; Martelli, M; Cantore, N; Raimondo, Fd; Petrini, M; de Fabritiis, P; Fioritoni, G; Nobile, F; Fabbiano, F; Specchia, G; Baccarani, M; Lo Coco, F; Amadori, S; Mandelli, Franco; Russo, D.
Aberrations of chromosome No. 1 in blastic phase of chronic myeloid leukemia. 1980 Alimena, Giuliana; B., Dallapiccola; F., Mitelman; A., Montuoro
Achievement of complete molecular responses in late chronic phase chronic myeloid leukaemia patients treated with pulsed imatinib while in minimal residual disease 2009 Massimo, Breccia; Laura, Cannella; Stefanizzi, Caterina; Michelina, Santopietro; Rosa De, Cuia; Daniela, Diverio; Alimena, Giuliana
Activity and safety of dasatinib as second-line treatment or in newly diagnosed chronic phase chronic myeloid leukemia patients 2011 Massimo, Breccia; Alimena, Giuliana
Acute leukaemia in patients treated for Hodgkin's disease 1984 G., Papa; Mauro, Francesca Romana; A. P., Anselmo; Cimino, Giuseppe; Alimena, Giuliana; E. D., D'Arcangelo; D., Giannarelli; A., Bosi; G., Bellesi; M., Fiacchini; P., Mazza; L., Babini; S., Emiliani; R., Maurizi Enrici; C., Bigini
Acute leukemia presenting a variant Ph chromosome with p190 expression, dup3q and -7, developed after malignant lymphoma treated with alkylating agents and topoisomerase II inhibitors. 1995 Alimena, Giuliana; Cedrone, M; Nanni, M; De Cuia, Mr; Lo Coco, F; De Sanctis, V; Cimino, Giuseppe; Mancini, M.
Acute lymphoblastic leukemia with the 4;11 translocation exhibiting early T-cell features. 1989 Lo Coco, F; Francia di Celle, P; Alimena, Giuliana; De Rossi, G; Gastaldi, R; Saglio, G; Foa, Roberto
Acute myeloblastic leukemia with t(8;21) following Philadelphia positive acute lymphoblastic leukemia. 1989 De Cuia, Mr; Alimena, Giuliana; Gastaldi, R; Aloe Spiriti, Ma; Giona, Fiorina; Mancini, M; Mandelli, Franco
Acute myelogenous leukemia in elderly patients not elegible for intensive chemotherapy: the dark side on the moon. 2006 Latagliata, R; Bongarzoni, V; Carmosino, I; Mengarelli, A; Breccia, M; ANTICOLI BORZA, P; D'Andrea, M; D'Elia, Gm; Mecarocci, S; Morano, Sg; Petti, Mc; Mandelli, Franco; Alimena, Giuliana